Advertisement

Advertisement

News

ASCO 2021: 2-Year Follow-up With Nivolumab/Ipilimumab Plus Chemotherapy for Advanced Lung Cancer

News

ASCO 2021: Impact of Lenvatinib-Based Therapy on Quality of Life in Renal Cell Carcinoma

News

ASCO 2021: Cemiplimab-rwlc and Quality of Life in Patients With Locally Advanced Skin Cancer

News

EHA2021: Iberdomide-Based Regimens for Relapsed or Refractory Multiple Myeloma

Medical Literature

Breast Tumor Microenvironment: Differences in Black Women?

News

ASCO 2021: Surgical Outcomes With Neoadjuvant Nivolumab Plus Chemotherapy in NSCLC

News

Treadmill and T Cells: Can Exercise Enhance Immune Responses in Breast Cancer?

Thomas Powles, MD, on Atezolizumab vs Chemotherapy in Urothelial Carcinoma

Cristina Saura, MD, on Choosing Neoadjuvant Treatment for Patients With Early Breast Cancer

View More

Advertisement

JNCCN Spotlights

Elotuzumab

(UPDATE) Daratumumab (MM)

Cetuximab (Head and Neck Cancers)

UPDATE Nivolumab and Ipilimumab in Renal Cell Carcinoma

View More

More

News

TRAXAR Trial: Adding Novel Monoclonal Antibody to Axitinib in Advanced Kidney Cancer

FDA Accepts Submission for Sintilimab in Combination With Pemetrexed/Platinum Chemotherapy in NSCLC

Does Performance Status Correlate With Survival in Pembrolizumab-Treated Patients With NSCLC?

APHINITY Trial Update: Adjuvant Pertuzumab-Based Therapy in Early HER2-Positive Breast Cancer

Nivolumab for Sarcomatoid Renal Cell Carcinoma With Metastases: Case Report

TROPHY-U-01 Supports Use of Sacituzumab Govitecan-hziy in Metastatic Urothelial Carcinoma

ASCO 2021: KEYNOTE-052 Survival Update on First-Line Pembrolizumab in Advanced Urothelial Cancer

Do Men and Women With Urinary Bladder Cancer Respond Differently to BCG Immunotherapy?

View More

Advertisement

Published

Medical Literature

Daratumumab Combination Therapy for Relapsed or Refractory Multiple Myeloma

Ixazomib Plus Lenalidomide/Dexamethasone in Relapsed or Refractory Myeloma: China Continuation Study

Combination Treatment With or Without Transplantation in Multiple Myeloma

Impact of Subsidies on Use of Immunomodulatory Drugs in Medicare Beneficiaries With Myeloma

View More

Ongoing

CE Activities

High-Rick Relapsing MM: Retreatment With Immunomodulatory Therapy

JADPRO Regional Lectures: Clinical Management of Novel Therapies for Hematologic Malignancies: Targeted Therapies, CAR-T, and Beyond

Changing Treatment Landscape of Metastatic Head and Neck Squamous Cell Carcinoma With Anti–PD-1/PD-L1 Agents

Consensus or Controversy? Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Locally Advanced Non–Small Cell Lung Cancer

View More

Available

Clinical Trials

Cancer Research Institute Immunotherapy Clinical Trials

Center for Immunotherapy Clinical Research Trials

Immunotherapy Clinical Trials at Fred Hutch Cancer Research Center

ClinicalTrials.gov Immunotherapy

View More

Resources

For Your Patients

ONS Immunotherapy News

ONS Immunotherapy Community

Society for Immunotherapy of Cancer Patient Resources

CancerCare on Immunotherapy

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2021 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.